Why the study?
Does n-3 PUFA supplementation and/or Mediterranean diet intervention improve endothelial function assessed by ADMA and L-arginine levels in elderly men with long-standing hyperlipidemia?
Does n-3 PUFA supplementation and/or Mediterranean diet intervention improve endothelial function assessed by ADMA and L-arginine levels in elderly men with long-standing hyperlipidemia?
Answers are grounded in this paper and cite their sources.
Long-term n-3 PUFA supplementation counteracts the age-related reduction in L-arginine levels, particularly in lean individuals, suggesting a potential mechanism for improved endothelial function, whereas ADMA levels remain unaffected.
BACKGROUND AND AIM: Impaired vasodilatation has been suggested to be caused by inhibition of nitric oxide generation by the recently described asymmetric dimethylarginine (ADMA). In the present study we wanted to explore whether n-3 polyunsaturated fatty acid (PUFA) supplementation and/or diet intervention have beneficial influence on endothelial function assessed as plasma levels of ADMA and L-arginine. METHODS: A male population (n = 563, age 70 +/- 6 yrs) with long-standing hyperlipidemia, characterized as high risk individuals in 1970-72, was included, randomly allocated to receive placebo n-3 PUFA capsules (corn oil) and no dietary advice (control group), dietary advice (Mediterranean type), n-3 PUFA capsules, or dietary advice and n-3 PUFA combined and followed for 3 years. Fasting blood samples were drawn at baseline and the end of the study. RESULTS: Compliance with both intervention regimens were demonstrated by changes in serum fatty acids and by recordings from a food frequency questionnaire. No influence of either regimens on ADMA levels were obtained. However, n-3 PUFA supplementation was accompanied by a significant increase in L-arginine levels, different from the decrease observed in the placebo group (p < 0.05). In individuals with low body mass index (<26 kg/m2), the decrease in L-arginine on placebo was strengthened (p = 0.01), and the L-arginine/ADMA ratio was also significantly reduced (p = 0.04). CONCLUSION: In this rather large randomized intervention study, ADMA levels were not influenced by n-3 PUFA supplementation or dietary counselling. n-3 PUFA did, however, counteract the age-related reduction in L-arginine seen on placebo, especially in lean individuals, which might be discussed as an improvement of endothelial function.
No takes yet. Share an insight, caveat, or question.
Eid et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: